|
Volumn 19 Suppl, Issue , 2002, Pages
|
Alemtuzumab, the first monoclonal antibody (MAb) directed against CD52.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
ANTINEOPLASTIC AGENT;
CANCER ANTIBODY;
MONOCLONAL ANTIBODY;
AGED;
B CELL LEUKEMIA;
EDITORIAL;
HUMAN;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
ANTINEOPLASTIC AGENTS;
HUMANS;
LEUKEMIA, B-CELL, CHRONIC;
|
EID: 0036367696
PISSN: 13570560
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (4)
|
References (0)
|